Multidrug Resistance-Associated Protein: A Protein Distinct from P-glycoprotein Involved in Cytotoxic Drug Expulsion

By Barrand M.A.   Bagrij T.   Neo S.-Y.  

General Pharmacology, Vol. 28, Iss. 5, 1997-05 ,pp. : 639-645

Elsevier

Access to resources Recommend Favorite

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite

Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers

By Arima Hidetoshi   Yunomae Kiyokazu   Morikawa Tadatoshi   Hirayama Fumitoshi   Uekama Kaneto  

Pharmaceutical Research, Vol. 21, Iss. 4, 2004-04 ,pp. : 625-634

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of Multidrug Resistance-Associated Protein 1 in Intestinal Toxicity of Methotrexate

By Kato Sayaka   Ito Katsuaki   Kato Yukio   Wakayama Tomohiko   Kubo Yoshiyuki   Iseki Shoichi   Tsuji Akira  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1467-1476

Springer Publishing Company

Access to resources Recommend Favorite

Defense Barriers in the Body:Contribution of Multidrug Resistance-Associated Protein 2

By Dietrich Christoph G.   Geier Andreas   Elferink Ronald P. J. Oude   Matern Siegfried  

Comments® on Toxicology, Vol. 9, Iss. 3-4, 2003-05 ,pp. : 201-214

Taylor & Francis Ltd

Access to resources Recommend Favorite